Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 916 across all filing types
Latest filing 2020-12-31 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (113 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2020-12-31 English
Sub.: Closure of Trading Window for dealing in securities of the Company in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015 Pursuant to the above Regulations, ....
Regulatory Filings
2020-12-31 English
Related Party Transactions
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and has a very short length (328 characters). There is no textual content indicating any financial data, report details, or announcements. It does not contain any report, announcement, or certification text. Given the lack of substantive content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2020-11-27 English
In Compliance with Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, we hereby submit the attached note on Related Party Transactions, ....
Regulatory Filings
2020-11-27 English
Financial Result Updates
Regulatory Filings
2020-11-12 English
This is with reference to the above mentioned subject, we would like to inform you that the Board of Directors of the Company at its meeting held today i.e. 12th November, 2020 has considered ....
Regulatory Filings
2020-11-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.